Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Company Provides Laboratories with Technologies for Swine Flu Detection

By LabMedica International staff writers
Posted on 14 May 2009
A company that provides innovative life-science solutions, announced that it is providing its technologies to health officials across the globe to aid in the identification of influenza strains, particularly the strain associated with the recent outbreak of the influenzavirus A H1N1, also known as swine flu.

Life Technologies (Gaithersburg, MD, USA), a company created by the combination of Invitrogen Corp. More...
(Carlsbad, CA, USA) and Applied Bios stems, Inc. (Foster City, CA, USA), has formed a special 24-hour-a-day task force across key business units to coordinate the company-wide response to global requests for assistance with the outbreak. The task force is leading efforts to provide health agencies with front-line support such as instrument training, managing the supply chain to ensure that products get to customers as quickly as possible, and ensuring appropriate regulatory compliance. Life Technologies is also accelerating the manufacture of components that will be used by laboratories to test for and identify influenza.

Through its Invitrogen and Applied Biosystems brands, Life Technologies offers components that support the workflow surrounding the identification of influenza virus strains. The company's products include the MagMAX viral RNA isolation kits for RNA purification; the SuperScript III; Platinum One-Step reverse transcriptase- polymerase chain reaction (qRT-PCR) kit for amplification of viral RNA; TaqMan Influenza A detection kit 2.0 for initial influenza type A screening; and several different capillary electrophoresis systems for determining the base-by-base sequence of viral samples. Additionally, the company offers its 7500 Fast and Fast Dx Real-Time PCR instruments under the Applied Biosystems brand.

"The spread of this new virus illustrates the importance of strong global surveillance programs," said Mark Stevenson, president and COO for Life Technologies. "Our technologies continue to be essential tools for public health agencies as they shift from reacting to the emergence of a potentially pandemic flu strain to proactively monitoring populations to identify the new strain as it arises."

Life Technologies is a global biotechnology tools company focused on improving the human condition. Life Technologies' customers do their work across the biologic spectrum, working to advance personalized medicine, molecular diagnostics, regenerative science, agricultural and environmental research, and 21st century forensics.

Related Links:
Life Technologies



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.